Form D · Other Technology
ELIXIR LAB USA INC.
Potomac, MD · CIK 0001920498
Offering snapshot reported Apr 19, 2022 · SEC filing
- Reported sold
- $3.9M Offering amount: $5.5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 12, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 19, 2022 | Initial | $3,900,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity, Debt, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-442488
This filing covers the purchase and sale of Convertible Promissory Notes ($2MM aggregate) and Common Stock ($3.5MM aggregate).
Convertible Note
Source: Form D, filed Apr 19, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Greg J. Baroni | Director |
| Kevin Jones | Executive |
| Thiagarajan Loganathan | Director, Executive, Promoter |
| Vijay Krishna Veeraraghavan | Executive, Promoter |
| Ganesharatnan Venkataramani | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
12713 Greenbriar Road
Potomac, MD, 20854
Potomac, MD, 20854